Belite Bio (NASDAQ:BLTE) reported second-quarter 2026 results and announced that the U.S. Food and Drug Administration accepted its New Drug Application for tinlarebant with Priority Review for Stargardt disease type 1.
Duolingo (NASDAQ:DUOL) announced the acquisition of Animade, a London-based animation and motion design studio, to expand its in-house Design Studio and support product experience development.
Pharming (NASDAQ:PHAR) announced the commercial launch of Joenja (leniolisib) in Japan for patients aged 4 years and older with activated PI3K delta syndrome (APDS), following its inclusion on Japan’s National Health Insurance drug price list.
Copper’s US arm has joined the Financial Industry Regulatory Authority (FINRA) after receiving approval from the US Securities and Exchange Commission to operate as a broker-dealer.
A large holder sold Hyperliquid (CRYPTO:HYPE) tokens, according to blockchain data cited by BitcoinWorld.
Uber Technologies (NYSE:UBER) announced that Uber Japan has partnered with Hinomaru Kotsu to manage fleet operations for an autonomous vehicle pilot in Tokyo scheduled to begin in late 2026.
SushiSwap (CRYPTO:SUSHI) has integrated with Bankr and Pools.fun to support token launches and liquidity pool activity.
Solana (CRYPTO:SOL) remained online after 102 of its 699 validators stopped voting, according to a report by crypto.news.
Zeotech (ASX:ZEO) signed a non-binding MOU with VINCI Construction to trial AusPozz high-performance metakaolin in concrete projects.
Proteomics International (ASX:PIQ) received a notice of acceptance from IP Australia for a patent covering its PromarkerEndo blood test.
GET YOUR GRAFA EDGE NOW
Sign up free to unlock this feature
We'll switch on a 30-day Edge trial as a welcome gift
